for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Koninklijke Philips NV

PHG.AS

Latest Trade

39.13EUR

Change

--(--)

Today's Range

--

 - 

--

52 Week Range

29.05

 - 

44.60

As of on the Euronext Amsterdam Stock Exchange ∙ Minimum 15 minute delay

Latest Developments

Philips Sees Q3 Group Adjusted EBITA At Around 583 Million Euros

Oct 10 (Reuters) - KONINKLIJKE PHILIPS NV <PHG.AS>::PHILIPS PROVIDES UPDATE ON ITS FINANCIAL PERFORMANCE IN Q3 2019.GROUP SALES FOR QUARTER ARE EXPECTED TO AMOUNT TO APPROXIMATELY EUR 4.7 BILLION.COMPARABLE ORDER INTAKE GROWTH IN Q3 IS EXPECTED TO BE FLAT ON BACK OF STRONG 11% GROWTH IN Q3 OF 2018.GROUP ADJUSTED EBITA FOR Q3 IS EXPECTED TO BE AROUND EUR 583 MILLION, OR 12.4% OF SALES, COMPARED TO 13.2% IN Q3 2018.Q3 NET INCOME FROM CONTINUING OPERATIONS IS EXPECTED TO AMOUNT TO APPROXIMATELY EUR 210 MILLION IN QUARTER.WE EXPECT THAT FULL YEAR 2019 ADJUSTED EBITA MARGIN IMPROVEMENT FOR GROUP WILL BE 10 TO 20 BASIS POINTS.FOR 2020, WE EXPECT TO DELIVER A 4-6% COMPARABLE SALES GROWTH AND AN ADJUSTED EBITA MARGIN IMPROVEMENT OF AROUND 100 BASIS POINTS.

Philips Signs Agreement To Create Digitalized Pathology Department In Taiwan

Aug 22 (Reuters) - Koninklijke Philips NV <PHG.AS>::PHILIPS SIGNS AGREEMENT TO CREATE TAIWAN’S FIRST FULLY DIGITALIZED PATHOLOGY DEPARTMENT.

Siemens Healthineers: We Don't Expect Philips To Intervene In Planned Acquisition Of Corindus

Aug 8 (Reuters) - Siemens Healthineers <SHLG.DE>::SAYS WE DON'T EXPECT PHILIPS <<<PHG.AS>>> TO INTERVENE IN OUR PLANNED ACQUISITION OF CORINDUS <<<CVRS.A>>>.

Philips Q2 Adjusted EBITA Beats Company-Compiled Poll

July 22 (Reuters) - Koninklijke Philips NV <PHG.AS>::PHILIPS DELIVERS Q2 SALES OF EUR 4.7 BILLION, WITH 6% COMPARABLE SALES GROWTH AND 8% COMPARABLE ORDER INTAKE GROWTH; INCOME FROM CONTINUING OPERATIONS INCREASES TO EUR 260 MILLION AND ADJUSTED EBITA MARGIN IMPROVES TO 11.8%.WE CONTINUE TO EXPECT OUR PERFORMANCE MOMENTUM TO FURTHER IMPROVE IN SECOND HALF OF YEAR.SALES IN QUARTER AMOUNTED TO EUR 4.7 BILLION, WITH 6% COMPARABLE SALES GROWTH.Q2 OPERATING CASH FLOW AMOUNTED TO EUR 390 MILLION, COMPARED TO EUR 130 MILLION IN Q2 2018; FREE CASH FLOW WAS EUR 174 MILLION.Q2 COMPARABLE ORDER INTAKE INCREASED 8%.WE MAINTAIN OUR OVERALL TARGETS FOR 2017-2020 PERIOD..Q2 INCOME FROM CONTINUING OPERATIONS INCREASED TO EUR 260 MILLION, COMPARED TO EUR 186 MILLION IN Q2 2018.Q2 EPS INCREASED AS INCOME FROM CONTINUING OPERATIONS PER SHARE (DILUTED) AMOUNTED TO EUR 0.28;.Q2 ADJUSTED EBITA MARGIN WAS 11.8% OF SALES, COMPARED TO 11.2% OF SALES IN Q2 2018.Q2 ADJUSTED EPS INCREASED 23% AS ADJUSTED INCOME FROM CONTINUING OPERATIONS PER SHARE (DILUTED) AMOUNTED TO EUR 0.43.Q2 INCOME FROM OPERATIONS INCREASED TO EUR 350 MILLION, COMPARED TO EUR 298 MILLION IN Q2 2018.Q2 ATTRIBUTABLE NET INCOME EUR 256 MILLION VERSUS EUR 239 MILLION IN COMPANY-COMPILED CONSENSUS.ADJUSTED EBITA MARGIN FOR GROUP IMPROVED BY 60 BASIS POINTS, MAINLY DRIVEN BY PERFORMANCE IMPROVEMENT OF DIAGNOSIS & TREATMENT BUSINESSES - CEO.Q2 ADJUSTED EBITA EUR 549 MLN VS EUR 542 MLN IN COMPANY-COMPILED CONSENSUS.

Royal Philips Acquires Boston-Based Start-Up Company Medumo

July 18 (Reuters) - Royal Philips::ROYAL PHILIPS - HAS EXPANDED ITS PATIENT MANAGEMENT SOLUTIONS IN U.S. WITH ACQUISITION OF BOSTON-BASED START-UP COMPANY MEDUMO.

Philips, Catholic University Of Korea Team Up To Improve Cancer Diagnosis

July 11 (Reuters) - Koninklijke Philips NV <PHG.AS>::CATHOLIC UNIVERSITY OF KOREA SEOUL ST. MARY'S HOSPITAL AND PHILIPS TEAM UP TO IMPROVE CANCER DIAGNOSIS.

Philips Receives PMA Approval For Sale Of 'Heartstart' Defibrillators In US

June 27 (Reuters) - Koninklijke Philips NV <PHG.AS>::PHILIPS RECEIVES PRE MARKET APPROVAL (PMA) FROM FDA FOR SALE OF 'HEARTSTART' DEFIBRILLATORS IN THE US.

BioBright And Philips Collaborate On New AI

June 25 (Reuters) - KONINKLIJKE PHILIPS NV <PHG.AS>::BIOBRIGHT AND PHILIPS COLLABORATE ON NEW AI TO IMPROVE THE PATIENT AND CLINICIAN EXPERIENCE.

Philips Receives FDA Premarket Approval For Its HeartStart OnSite and HeartStart Home Defibrillators

June 19 (Reuters) - Koninklijke Philips NV <PHG.AS>::PHILIPS RECEIVES FDA PREMARKET APPROVAL FOR ITS HEARTSTART ONSITE AND HEARTSTART HOME DEFIBRILLATORS.

Philips IntelliSite Pathology Solution To Be Deployed Across Mount Sinai Health System

June 18 (Reuters) - KONINKLIJKE PHILIPS NV <PHG.AS>::PHILIPS INTELLISITE PATHOLOGY SOLUTION WILL BE DEPLOYED ACROSS THE MOUNT SINAI HEALTH SYSTEM TO SUPPORT GREATER EFFICIENCY AND HELP IMPROVE PATIENT CARE.LABCORP AND MOUNT SINAI HEALTH SYSTEM COLLABORATE TO ESTABLISH DIGITAL AND AI-ENABLED PATHOLOGY CENTER OF EXCELLENCE.IMPLEMENTATION OF CLINICAL PHILIPS INTELLISITE PATHOLOGY SOLUTION IS UNDERWAY AND MOUNT SINAI EXPECTS TO BEGIN ITS USE IN NEXT SEVERAL MONTHS.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up